| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 38.75B | 38.70B | 35.08B | 31.68B | 28.14B | 24.68B |
| Gross Profit | 23.09B | 22.99B | 21.00B | 18.70B | 16.17B | 13.60B |
| EBITDA | 6.99B | 7.23B | 6.47B | 5.40B | 4.52B | 3.26B |
| Net Income | 4.05B | 4.32B | 3.65B | 3.13B | 2.55B | 1.67B |
Balance Sheet | ||||||
| Total Assets | 50.18B | 49.99B | 50.09B | 43.73B | 40.71B | 37.81B |
| Cash, Cash Equivalents and Short-Term Investments | 9.96B | 10.89B | 9.72B | 9.58B | 9.06B | 6.94B |
| Total Debt | 1.87B | 213.00M | 281.00M | 1.19B | 1.48B | 1.87B |
| Total Liabilities | 7.51B | 7.26B | 8.48B | 8.21B | 7.77B | 7.62B |
| Stockholders Equity | 42.58B | 42.66B | 41.53B | 35.44B | 32.87B | 30.14B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.22B | 1.38B | 1.54B | 2.67B | 1.73B |
| Operating Cash Flow | 0.00 | 3.45B | 3.09B | 3.17B | 3.74B | 2.83B |
| Investing Cash Flow | 0.00 | -914.00M | -1.29B | -1.29B | -1.29B | -4.08B |
| Financing Cash Flow | 0.00 | -1.78B | -2.10B | -1.46B | -1.07B | 3.02B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥46.72B | 11.38 | ― | 3.21% | 12.92% | 29.48% | |
74 Outperform | ¥119.36B | 23.11 | 5.97% | 1.78% | 3.17% | 7.07% | |
73 Outperform | ¥146.30B | 31.12 | ― | 2.73% | 5.10% | -26.13% | |
69 Neutral | ¥64.52B | 14.34 | ― | 2.83% | 3.69% | 1.86% | |
67 Neutral | ¥17.07B | 12.46 | ― | 2.65% | 0.81% | -26.76% | |
59 Neutral | ¥144.02B | 257.19 | 0.78% | 1.31% | -2.06% | -79.17% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
Shofu Inc. reported a slight increase in consolidated net sales for the first half of the fiscal year ending March 2026, with a 1.1% year-over-year growth. The dental business remains a major contributor to sales, although there was a minor decline in overseas sales. The company also noted a significant increase in R&D expenses, indicating a focus on innovation and product development.
Shofu Inc. reported its consolidated financial results for the six months ending September 30, 2025, showing a slight increase in net sales by 1.1% to 19,095 million yen. However, operating income decreased by 7.5% compared to the previous year. The company experienced a significant rise in comprehensive income by 313.2% to 2,896 million yen, indicating improved profitability despite the decline in operating income. The company also noted a two-for-one stock split, affecting the calculation of earnings per share. The financial outlook for the fiscal year ending March 31, 2026, projects a 5.6% increase in net sales, with a slight decrease in operating and ordinary income, but an 8.9% increase in net income attributable to owners of the parent.
Shofu Inc. has revised its earnings forecast for the first half of the fiscal year ending March 31, 2026, due to lower-than-expected demand in Japan and challenging overseas business conditions. Despite a decrease in net sales, the company anticipates higher operating and ordinary income due to deferred expenses and increased net income from the early sale of cross-shareholdings. The full-year earnings forecast remains unchanged, with the company aiming to maintain profitability while monitoring the business environment.